New York · Bipolar Depression

Valproate for bipolar depression: where it fits and where it doesn’t

Valproate is a well-known mood stabilizer for mania, but its role in bipolar depression is more limited, and its pregnancy risks are serious.

Need help now? If you’re thinking about suicide or feel unsafe, call or text 988, or call 911.

Quick Answer

Valproate for bipolar depression has a limited role. It's used mainly for mania and maintenance, while other medications are approved specifically for bipolar depression. Its FDA label carries boxed warnings for fetal risk, including neural tube defects and decreased IQ, plus liver toxicity and pancreatitis, and it should not be used in women of childbearing potential unless other options fail.

Understanding valproate for Bipolar Depression

Valproate, often prescribed as divalproex, is a mood stabilizer widely used for acute mania and for long-term prevention of mood episodes. Its role in bipolar depression is more limited. Several medications are FDA-approved specifically for bipolar depression, including quetiapine, lurasidone, olanzapine-fluoxetine, cariprazine and lumateperone, and lithium and lamotrigine are commonly used in long-term care. A 2024 review noted that the CANMAT and ISBD guidelines list lurasidone in combination with valproate among first-line options, which is one way valproate appears in bipolar depression treatment: as a base mood stabilizer to which another medication is added. This guide is part of Dr. Farkas's New York bipolar resources.

Valproate’s most important limitation is its safety profile, especially in pregnancy. Its FDA prescribing information carries boxed warnings for hepatotoxicity, fetal risk and pancreatitis. The label states valproate can cause major congenital malformations, particularly neural tube defects like spina bifida, as well as decreased IQ and neurodevelopmental disorders after exposure in the womb. It says valproate should not be used to treat women with bipolar disorder who are pregnant or planning pregnancy, or women of childbearing potential, unless other medications have failed or are otherwise unacceptable. Our guide on bipolar pregnancy planning covers safer planning.

For New Yorkers of childbearing age, understanding valproate’s limits before starting can prevent hard decisions later. According to the NYC Health Department, only 46% of adult New Yorkers felt they could count on someone for emotional support most or all of the time in 2023. Secure video visits from anywhere in New York can make it easier to start bipolar care and keep regular follow-ups without extra travel.

Valproate’s role in bipolar disorder, pregnancy and childbearing risks, and liver and pancreas monitoring are the three topics this guide covers.

Interaction with lamotrigine

The lamotrigine prescribing information notes that valproate increases lamotrigine concentrations more than twofold. When the two are combined, lamotrigine must be started at a lower dose and increased more slowly to reduce the risk of serious rash. This combination is sometimes used, but it requires careful planning. Tell every prescriber that you take valproate.

Men and valproate

Valproate’s fetal risks apply to pregnancy, but men taking valproate should still discuss family planning with their prescriber, since guidance continues to evolve. Weight gain, tremor and liver monitoring apply to everyone. The decision to use valproate is individual.

The Bottom Line

Valproate for Bipolar Depression is common and treatable, and careful care can make daily life feel more manageable.

Frequently Asked Questions

Is valproate used for bipolar depression?

Valproate is used mainly for mania and long-term prevention, not as a first choice for bipolar depression. Several medications are FDA-approved specifically for bipolar depression. Guidelines list lurasidone combined with valproate among first-line options. That's one way valproate appears in bipolar depression care. Your prescriber will explain where it fits.

Why is valproate risky in pregnancy?

The FDA label warns valproate can cause major birth defects, particularly neural tube defects like spina bifida. It can also cause decreased IQ and neurodevelopmental disorders after exposure in the womb. It should not be used in pregnant women with bipolar disorder unless other medications have failed. Women of childbearing potential should avoid it unless essential. Discuss plans with your prescriber.

What should I do if I get pregnant on valproate?

Contact your prescriber right away. Don't stop valproate suddenly on your own, since abrupt changes can trigger relapse. A careful transition plan is needed. Your obstetric provider should be involved. Planning ahead is safer whenever possible. An evaluation can clarify what's happening and which options fit.

What monitoring is needed on valproate?

Liver tests are checked before starting and periodically afterward. Blood counts, including platelets, and valproate levels may be monitored. Symptoms like yellowing skin, vomiting or abdominal pain need prompt attention. Pancreatitis requires urgent care. Weight and tremor are also tracked. An evaluation can clarify what's happening and which options fit.

Does valproate interact with lamotrigine?

Yes, the lamotrigine label notes valproate increases lamotrigine levels more than twofold. Lamotrigine must start at a lower dose and increase more slowly. This reduces the risk of serious rash. The combination requires careful planning. Tell every prescriber you take valproate. An evaluation can clarify what's happening and which options fit.

Can valproate be managed by video in New York?

Yes, valproate follow-ups happen by secure video anywhere in New York, with labs drawn at a lab near you. You need to be physically in New York during each visit. Prescriptions go electronically to your pharmacy. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office. Pregnancy planning is part of the conversation.

Key Takeaways

Dr. Gabriella I. Farkas, MD PhD, close-up portrait
  • Valproate is used mainly for mania and maintenance, not as a first choice for bipolar depression.
  • Its label carries boxed warnings for fetal risk, liver toxicity and pancreatitis.
  • It should not be used in women who could become pregnant unless other options have failed.
  • Valproate raises lamotrigine levels more than twofold.

Valproate for Bipolar Depression at a glance

Valproate boxed warnings (FDA label)
WarningSummary
Fetal riskNeural tube defects, other malformations, decreased IQ
HepatotoxicitySerious liver injury; monitor liver tests
PancreatitisIncluding fatal cases
Childbearing potentialAvoid unless other medications fail
InteractionRaises lamotrigine levels more than 2-fold

If you could become pregnant

If you’re a woman who could become pregnant, valproate is generally avoided unless other options haven’t worked. If it is used, effective contraception and a clear plan are essential, and folic acid is often recommended. Never stop valproate suddenly on your own if you learn you’re pregnant; contact your prescriber right away, since abrupt changes can trigger relapse and a careful transition plan is needed. Discuss pregnancy plans well in advance.

Liver and pancreas monitoring

Liver tests are checked before starting valproate and periodically afterward, especially in the first months. Symptoms like unusual fatigue, loss of appetite, vomiting, yellowing skin or eyes, or abdominal pain need prompt attention. Pancreatitis can cause severe abdominal pain, nausea and vomiting and requires urgent care. Blood counts, including platelets, and valproate levels may also be monitored. Weight gain and tremor are common side effects. Our guides on bipolar pregnancy planning and lamotrigine and birth control cover related topics.

Valproate care for New York patients

Valproate follow-ups can happen by secure video, with labs drawn locally. Visits run by secure video anywhere in New York, while you’re physically in the state. The practice is in-network with Aetna and Cigna; confirm your New York plan with the office, and see self-pay fees on the Good Faith Estimate page.

Alternatives

For bipolar depression specifically, approved options and lithium or lamotrigine are usually considered before or alongside valproate. Your prescriber will compare options based on your history, side effects and life plans. Switching is done gradually to avoid relapse.

When to seek help

Seek urgent care for severe abdominal pain, vomiting, yellowing of the skin or eyes, or unusual bruising while taking valproate. Contact your prescriber immediately if you become pregnant. Thoughts of suicide need immediate help through 988, and call 911 in an emergency. Valproate can help some people when its limits are respected.

If you’d like help sorting this out, you can request an evaluation by secure video anywhere in New York.
Illustration of a human brain
Middle-aged adult talking with a mental health clinician during an appointment
An evaluation starts with your history: when symptoms began and what they're affecting.

Where to go from here

Right now, if you're not safe
Call or text 988, or call 911.
If you'd like an evaluation
See how scheduling and telehealth work on the new patient page.
If you want to keep reading
Return to our full set of New York bipolar depression guides for more guides. For more help preparing and finding care, see NIMH’s tips for talking with your health care provider.

How We Reviewed This Page

Written by Steven Lockhart of Health Marketing Group and clinically reviewed by Gabriella I. Farkas, MD PhD, a board-certified psychiatrist. Clinical information comes from the sources listed below, and the page is reviewed every 180 days or when guidance changes.

What’s new: September 29, 2026. Page published.

References

  1. AbbVie. DEPAKOTE (divalproex sodium) Prescribing Information. https://www.rxabbvie.com/pdf/depakote.pdf
  2. FDA. LAMICTAL (lamotrigine) Prescribing Information (2025). https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020241s068s069%2C020764s061s062%2C022251s032s033lbl.pdf
  3. NYC Health Department. The State of Mental Health of New Yorkers (2024). https://www.nyc.gov/assets/doh/downloads/pdf/mh/state-of-mental-health-new-yorkers.pdf
  4. 988 Suicide & Crisis Lifeline. https://988lifeline.org/
  5. Tips for talking with your health care provider. https://www.nimh.nih.gov/health/publications/tips-for-talking-with-your-health-care-provider
Medical Disclaimer This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Only an evaluation can tell you what is going on. Gabriella I. Farkas, MD PhD, is licensed in South Carolina and New York; patients must be physically located in one of those states during telehealth visits.
Vital Voice Online

Schedule a Consultation

Fill out the form below and we'll get back to you within 24 hours.

Request Sent!

We've received your request and will be in touch within 24 hours.

Something went wrong